Neuroelectrics, a pioneer in high-definition brain stimulation and EEG technology, has partnered with Neuronostics, an innovator in advanced digital biomarkers and EEG analysis, to deliver an integrated EEG solution tailored for the pharmaceutical, contract research organisations (CROs) and academic partners.
This collaboration combines Neuroelectrics’ cutting-edge EEG hardware with Neuronostics’ proprietary analytics to streamline clinical trials and unlock new possibilities in neurological research.
A Game-Changing CollaborationThe partnership addresses a critical need in clinical trials for high-quality, actionable data by providing an integrated platform that accelerates research and improves outcomes. Leveraging Neuronostics’ proprietary BioEP tool and Neuroelectrics’ premium EEG technology, the platform enhances cohort identification, streamlines protocol design, and delivers precise EEG analysis, ensuring trials are both efficient and impactful.
John Terry, Managing Director at Neuronostics said: “This collaboration with Neuroelectrics creates a powerful offering that will enable EEG and digital biomarkers to make clinical trials more efficient and effective, leading to significant benefits for people with neurological conditions.”
Ana Maiques, CEO of Neuroelectrics added: “At Neuroelectrics, we believe in advancing brain health through innovation. Our partnership with Neuronostics elevates clinical trials by integrating the best in EEG technology and analytics, enabling breakthroughs in neurology and psychiatry.
Targeted Cohort Identification: The integrated EEG tool assists in identifying participants with the highest seizure burden through a brief 20-minute EEG. This targeted approach saves time and enhances statistical significance in trials.
Comprehensive Data Analysis: Certified neurophysiologists combine clinical expertise with Neuronostics’ cloud-based digital tools to deliver robust, actionable EEG insights tailored to trial objectives.
Optimised Protocol Design: Experts collaborate with sponsors to create trial protocols aligned with study goals, ensuring streamlined processes and reliable results.
